The Latin America, Middle East and Africa Urinalysis Test Market should witness market growth of 11.8% CAGR during the forecast period (2023-2029).
Urinalysis can be used to check for compounds, including glucose, leucocytes, nitrite, and blood, that is not typically anticipated to be present in urine. Additional urine and/or blood testing may be necessary if these chemicals are found. A urine test is a reliable screening tool for finding infections and systemic illnesses. Urine specimens can be collected using various techniques, but limiting contamination is crucial to prevent unreliable results. Reagent strips are a quick and simple way to test urine, and they can provide important details about a patient's health.
New urine testing equipment has been created as a result of the growing demand for point-of-care diagnostic testing. These tools are perfect to be utilized in outpatient clinics, emergency rooms, and other healthcare settings since they provide prompt and precise findings. Technology developments have also led to the creation of automated urinalysis devices, perfect for use in high-throughput clinical laboratories since they deliver prompt and accurate findings.
Many factors, including unhealthy lifestyles, genetic predisposition, and an increase in type 2 diabetes mellitus among children and young people, impact this region's prevalence of the disease. There are numerous people who have diabetes as a result of various circumstances. In Qatar, the prevalence of T2DM increased from 7.0% to 14.0% between 2021 and 2050, as did the number of people living with the condition (170 057 to 596 862) and the annual number of new cases (25 007 to 45 155) of T2DM. The growth of diabetic patients due to various reasons in the region will also increase the need for precise diagnosis methods like urinalysis tests to identify people suffering from diabetes and thereby drive the market growth in the region.
The Brazil market dominated the LAMEA Urinalysis Test Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $133.5 Million by 2029. The Argentina market is experiencing a CAGR of 12.3% during (2023-2029). Additionally, The UAE market would display a CAGR of 11.2% during (2023-2029).
Based on Product, the market is segmented into Consumables and Instruments. Based on Application, the market is segmented into Disease Screening and Pregnancy & Fertility. Based on End-user, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Homecare. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Siemens Healthineers AG (Siemens AG), ACON Laboratories, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Arkray, Inc., Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Becton, Dickinson and Company.
Urinalysis can be used to check for compounds, including glucose, leucocytes, nitrite, and blood, that is not typically anticipated to be present in urine. Additional urine and/or blood testing may be necessary if these chemicals are found. A urine test is a reliable screening tool for finding infections and systemic illnesses. Urine specimens can be collected using various techniques, but limiting contamination is crucial to prevent unreliable results. Reagent strips are a quick and simple way to test urine, and they can provide important details about a patient's health.
New urine testing equipment has been created as a result of the growing demand for point-of-care diagnostic testing. These tools are perfect to be utilized in outpatient clinics, emergency rooms, and other healthcare settings since they provide prompt and precise findings. Technology developments have also led to the creation of automated urinalysis devices, perfect for use in high-throughput clinical laboratories since they deliver prompt and accurate findings.
Many factors, including unhealthy lifestyles, genetic predisposition, and an increase in type 2 diabetes mellitus among children and young people, impact this region's prevalence of the disease. There are numerous people who have diabetes as a result of various circumstances. In Qatar, the prevalence of T2DM increased from 7.0% to 14.0% between 2021 and 2050, as did the number of people living with the condition (170 057 to 596 862) and the annual number of new cases (25 007 to 45 155) of T2DM. The growth of diabetic patients due to various reasons in the region will also increase the need for precise diagnosis methods like urinalysis tests to identify people suffering from diabetes and thereby drive the market growth in the region.
The Brazil market dominated the LAMEA Urinalysis Test Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $133.5 Million by 2029. The Argentina market is experiencing a CAGR of 12.3% during (2023-2029). Additionally, The UAE market would display a CAGR of 11.2% during (2023-2029).
Based on Product, the market is segmented into Consumables and Instruments. Based on Application, the market is segmented into Disease Screening and Pregnancy & Fertility. Based on End-user, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Homecare. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Siemens Healthineers AG (Siemens AG), ACON Laboratories, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Arkray, Inc., Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Becton, Dickinson and Company.
Scope of the Study
By Product
- Consumables
- Instruments
By Application
- Disease Screening
- Pregnancy & Fertility
By End-user
- Diagnostic Laboratories
- Hospitals & Clinics
- Homecare
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Cardinal Health, Inc.
- Siemens Healthineers AG (Siemens AG)
- ACON Laboratories, Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- Arkray, Inc.
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Urinalysis Test Market by Product
Chapter 5. LAMEA Urinalysis Test Market by Application
Chapter 6. LAMEA Urinalysis Test Market by End User
Chapter 7. LAMEA Urinalysis Test Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Cardinal Health, Inc.
- Siemens Healthineers AG (Siemens AG)
- ACON Laboratories, Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- Arkray, Inc.
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
Methodology
LOADING...
